Table 2.
Summary of studies comparing transperineal ultrasound with magnetic resonance imaging or surgical findings in perianal Crohn’s disease and inflammatory bowel disease
|
Ref.
|
No. of patients
|
Patient characteristics
|
Concordance rate (TPUS vs MRI or surgery)
|
Main findings
|
| Maconi et al[2], 2013 | 59 | Adults with CD, prospective | κ = 0.78 (fistulae classification) | TPUS sensitivity 94%, PPV 93%; less accurate for extrasphincteric/suprasphincteric tracts and deep abscesses |
| Bor et al[16], 2016 | 23 | Adults with complicated CD | Not specified | TPUS 100% sensitivity for fistulae and abscesses; outperformed MRI and TRUS |
| Jung et al[13], 2022 | 29 | Pediatric CD on biologics | κ = 0.49 | TPUS had high specificity (93%) and PPV (95%) for assessing treatment response vs MRI |
| Lee et al[12], 2018 | 38 | Pediatric CD with PACD | κ = 0.30-0.62 | TPUS better concordance with MRI than colonoscopy; sensitivity 76% for fistulae, 56% for abscesses |
| Wedemeyer et al[18], 2004 | 25 | Adults with active PACD | κ > 0.83 | TPUS detected 90% of fistulas and 86% of abscesses; comparable to MRI; especially useful in anal stenosis |
| Terracciano et al[17], 2016 | 28 | IBD patients | Sensitivity 100% for RVF and superficial abscess; κ = 0.34 for deep abscess | TPUS highly concordant with MRI for Parks (κ = 0.67) and AGA (κ = 0.83) classifications; superior for RVF and superficial abscesses |
TPUS: Transperineal ultrasound; MRI: Magnetic resonance imaging; CD: Crohn’s disease; PACD: Perianal Crohn’s disease; TRUS: Transrectal ultrasound; RVF: Rectovaginal fistula; AGA: American Gastroenterological Association, κ: Cohen’s kappa statistic; PPV: Positive predictive value.